Concentric left ventricular hypertrophy as assessed by cardiac magnetic resonance imaging and risk of death in cardiac transplant recipients

Journal of Heart and Lung Transplantation

Volumn 29, Issue 12, 2010, Pages 1369-1379

  Patel, Parag C ^a   Reimold, Sharon C ^a   Araj, Faris G ^a   Ayers, Colby R ^a   Kaiser, Patricia A ^a   Peshock, Ronald M ^a   Yancy, Clyde W ^b   Ring, W Steves ^a   Gupta, Sachin ^a   Mishkin, Joseph D ^a   Mammen, Pradeep P A ^a   Markham, David W ^a   Drazner, Mark H ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

diastole; humans; imaging; left ventricular hypertrophy; magnetic resonance; mortality; multivariate analysis; prognosis; transplantation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; BASILIXIMAB; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ORAL ANTIDIABETIC AGENT; PREDNISONE;

ADULT; ARTICLE; DEATH; DIABETES MELLITUS; FEMALE; GRAFT REJECTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; CAUSE OF DEATH; FEMALE; HEART TRANSPLANTATION; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78649324565     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.05.008     Document Type: Article

References (46)

1. D.A. Bluemke, R.A. Kronmal, and J.A. Lima The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study J Am Coll Cardiol 52 2008 2148 2155
2. J.K. Ghali, Y. Liao, and R.S. Cooper Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease J Am Coll Cardiol 31 1998 1635 1640
3. M.J. Koren, R.B. Devereux, P.N. Casale, D.D. Savage, and J.H. Laragh Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension Ann Intern Med 114 1991 345 352
4. P. Verdecchia, G. Schillaci, and C. Borgioni Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy Am J Cardiol 78 1996 197 202
5. A. Verma, A. Meris, and H. Skali Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study JACC Cardiovasc Imaging 1 2008 582 591
6. D. Farge, J. Julien, and C. Amrein Effect of systemic hypertension on renal function and left ventricular hypertrophy in heart transplant recipients J Am Coll Cardiol 15 1990 1095 1101 (Pubitemid 20104568)
7. H.O. Ventura, C.J. Lavie, and F.H. Messerli Cardiovascular adaptation to cyclosporine-induced hypertension J Hum Hypertens 8 1994 233 237
8. R.C. McKoy, B.F. Uretsky, R. Kormos, R.L. Hardesty, B.P. Griffith, and R. Salerni Left ventricular hypertrophy in cyclosporine-induced systemic hypertension after cardiac transplantation Am J Cardiol 62 1988 1140 1142
9. G.H. Jenkins, and D.R. Singer Hypertension in thoracic transplant recipients J Hum Hypertens 12 1998 813 823
10. M.T. Olivari, A. Antolick, and W.S. Ring Arterial hypertension in heart transplant recipients treated with triple-drug immunosuppressive therapy J Heart Transplant 8 1989 34 39
11. S.J. Stetson, A. Perez-Verdia, and W. Mazur Cardiac hypertrophy after transplantation is associated with persistent expression of tumor necrosis factor-alpha Circulation 104 2001 676 681
12. R. Goodroe, D.D. Bonnema, and S. Lunsford Severe left ventricular hypertrophy 1 year after transplant predicts mortality in cardiac transplant recipients J Heart Lung Transplant 26 2007 145 151
13. E. Raichlin, H.R. Villarraga, and K. Chandrasekaran Cardiac allograft remodeling after heart transplantation is associated with increased graft vasculopathy and mortality Am J Transplant 9 2009 132 139
14. P.C. Patel, C.R. Ayers, and S.A. Murphy Association of cystatin C with left ventricular structure and function: the Dallas Heart Study Circ Heart Fail 2 2009 98 104
15. S. Gupta, J.D. Mitchell, and D.W. Markham High incidence of cytomegalovirus disease in D+/R heart transplant recipients shortly after completion of 3 months of valganciclovir prophylaxis J Heart Lung Transplant 27 2008 536 539
16. P.B. Rosenberg, A.E. Vriesendorp, and M.H. Drazner Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation J Heart Lung Transplant 24 2005 1327 1331
17. M. Sokolow, and T.P. Lyon The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads Am Heart J 37 1949 161 186
18. P.N. Casale, R.B. Devereux, D.R. Alonso, E. Campo, and P. Kligfield Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings Circulation 75 1987 565 572
19. S. Stewart, G.L. Winters, and M.C. Fishbein Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection J Heart Lung Transplant 24 2005 1710 1720
20. M. Wilhelmi, K. Pethig, M. Wilhelmi, H. Nguyen, M. Struber, and A. Haverich Heart transplantation: echocardiographic assessment of morphology and function after more than 10 years of follow-up Ann Thorac Surg 74 2002 1075 1079
21. J.A. Hill, and E.N. Olson Cardiac Plasticity N Engl J Med 358 2008 1370 1380
22. N.J. Kertesz, R.J. Gajarski, J.A. Towbin, and T. Geva Effect of donor-recipient size mismatch on left ventricular remodeling after pediatric orthotopic heart transplantation The American Journal of Cardiology 76 1995 1167 1172
23. P.J. Mather, V. Jeevanandam, and H.J. Eisen Functional and morphologic adaptation of undersized donor hearts after heart transplantation J Am Coll Cardiol 26 1995 737 742
24. R.A. Rowan, and M.E. Billingham Pathologic changes in the long-term transplanted heart: A morphometric study of myocardial hypertrophy, vascularity, and fibrosis Human Pathol 21 1990 767 772
25. A.T. Armstrong, P.F. Binkley, P.B. Baker, P.D. Myerowitz, and C.V. Leier Quantitative investigation of cardiomyocyte hypertrophy and myocardial fibrosis over 6 years after cardiac transplantation J Am Coll Cardiol 32 1998 704 710
26. D.V. Miller, R.J. Rodeheffer, S.S. Kushwaha, R.P. Frantz, A.L. Clavell, and N.L. Pereira 465: cellular changes associated with increased left ventricular mass following cardiac transplantation J Heart Lung Transplant 28 suppl 2009 S227
27. K. Eguchi, B. Boden-Albala, and Z. Jin Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population Am J Cardiol 101 2008 1787 1791
28. Z.Y. Fang, S. Yuda, V. Anderson, L. Short, C. Case, and T.H. Marwick Echocardiographic detection of early diabetic myocardial disease J Am Coll Cardiol 41 2003 611 617
29. R.S. Velagaleti, P. Gona, and M.L. Chuang Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study Circ Cardiovasc Imaging 2010 [e-pub doi: 10.1161/CIRCIMAGING.109.911438 ]
30. R. Candido, J.M. Forbes, and M.C. Thomas A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes Circ Res 92 2003 785 792
31. H. Taegtmeyer, P. McNulty, and M.E. Young Adaptation and maladaptation of the heart in diabetes: part I: general concepts Circulation 105 2002 1727 1733 (Pubitemid 34298619)
32. S.K. Mehta, J.E. Rame, and A. Khera Left ventricular hypertrophy, subclinical atherosclerosis, and inflammation Hypertension 49 2007 1385 1391
33. Y.T. Zhou, P. Grayburn, and A. Karim Lipotoxic heart disease in obese rats: implications for human obesity Proc Natl Acad Sci U S A 97 2000 1784 1789
34. M.E. Young, P. McNulty, and H. Taegtmeyer Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms Circulation 105 2002 1861 1870 (Pubitemid 34408899)
35. P. Verdecchia, G. Carini, and A. Circo Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study J Am Coll Cardiol 38 2001 1829 1835
36. M.H. Drazner, J.E. Rame, and E.K. Marino Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study J Am Coll Cardiol 43 2004 2207 2215
37. N.G. Bellenger, N.J. Marcus, C. Davies, M. Yacoub, N.R. Banner, and D.J. Pennell Left ventricular function and mass after orthotopic heart transplantation: a comparison of cardiovascular magnetic resonance with echocardiography J Heart Lung Transplant 19 2000 444 452
38. M.H. Drazner, D.L. Dries, and R.M. Peshock Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study Hypertension 46 2005 124 129
39. S. Aziz, L.A. Soine, and S.L. Lewis Donor left ventricular hypertrophy increases risk for early graft failure Transpl Int 10 1997 446 450
40. S. Goland, L.S. Czer, and R.M. Kass Use of cardiac allografts with mild and moderate left ventricular hypertrophy can be safely used in heart transplantation to expand the donor pool J Am Coll Cardiol 51 2008 1214 1220
41. D. Marelli, H. Laks, D. Fazio, S. Moore, J. Moriguchi, and J. Kobashigawa The use of donor hearts with left ventricular hypertrophy J Heart Lung Transplant 19 2000 496 503
42. C.E. Angermann, C.H. Spes, S. Willems, P. Dominiak, B.M. Kemkes, and K. Theisen Regression of left ventricular hypertrophy in hypertensive heart transplant recipients treated with enalapril, furosemide, and verapamil Circulation 84 1991 583 593
43. L.H. Opie, M. Haus, P.J. Commerford, B. Levetan, K. Moore, and J. Brink Antihypertensive effects of angiotensin converting enzyme inhibition by lisinopril in post-transplant patients Am J Hypertens 15 2002 911 916
44. J.L. Peura, M.R. Zile, and D.S. Feldman Effects of conversion from cyclosporine to tacrolimus on left ventricular structure in cardiac allograft recipients J Heart Lung Transplant 24 2005 1969 1972
45. S.S. Kushwaha, E. Raichlin, and Y. Sheinin Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients Eur Heart J 29 2008 2742 2750
46. J. Schwitter, T. De Marco, and S. Globits Influence of felodipine on left ventricular hypertrophy and systolic function in orthotopic heart transplant recipients: possible interaction with cyclosporine medication J Heart Lung Transplant 18 1999 1003 1013